EFNS guidelines on diagnosis and management of neuromyelitis optica J Sellner, M Boggild, M Clanet, RQ Hintzen, Z Illes, X Montalban, ... European journal of neurology 17 (8), 1019-1032, 2010 | 634 | 2010 |
The increasing incidence and prevalence of female multiple sclerosis—a critical analysis of potential environmental factors J Sellner, J Kraus, A Awad, R Milo, B Hemmer, O Stüve Autoimmunity reviews 10 (8), 495-502, 2011 | 272 | 2011 |
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation MC Kowarik, S Cepok, J Sellner, V Grummel, MS Weber, T Korn, ... Journal of neuroinflammation 9, 1-11, 2012 | 253 | 2012 |
The role of TH17 cells in multiple sclerosis: Therapeutic implications T Moser, K Akgün, U Proschmann, J Sellner, T Ziemssen Autoimmunity reviews 19 (10), 102647, 2020 | 221 | 2020 |
European consensus‐based (S2k) guideline on the Management of Herpes Zoster–guided by the European dermatology forum (EDF) in cooperation with the European academy of … RN Werner, AF Nikkels, B Marinović, M Schäfer, M Czarnecka‐Operacz, ... Journal of the European Academy of Dermatology and Venereology 31 (1), 20-29, 2017 | 204 | 2017 |
Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: a systematic review and meta‐analysis T Baldini, GM Asioli, M Romoli, M Carvalho Dias, EC Schulte, L Hauer, ... European journal of neurology 28 (10), 3478-3490, 2021 | 179 | 2021 |
Immunological aspects of approved MS therapeutics PS Rommer, R Milo, MH Han, S Satyanarayan, J Sellner, L Hauer, Z Illes, ... Frontiers in immunology 10, 1564, 2019 | 169 | 2019 |
The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes J Sellner, B Hemmer, M Mühlau Journal of autoimmunity 34 (4), 371-379, 2010 | 168 | 2010 |
Vitamin D supplementation in multiple sclerosis: a critical analysis of potentials and threats J Feige, T Moser, L Bieler, K Schwenker, L Hauer, J Sellner Nutrients 12 (3), 783, 2020 | 147 | 2020 |
The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection E Moro, A Priori, E Beghi, R Helbok, L Campiglio, CL Bassetti, E Bianchi, ... European journal of neurology 27 (9), 1727-1737, 2020 | 137 | 2020 |
Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities UK Meyding-Lamadé, C Oberlinner, PR Rau, S Seyfer, S Heiland, ... Journal of neurovirology 9 (1), 118-125, 2003 | 135 | 2003 |
In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation J Sellner, SL Leib Neurobiology of disease 21 (3), 647-656, 2006 | 116 | 2006 |
A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ... European journal of neurology 27 (9), 1712-1726, 2020 | 113 | 2020 |
European consensus‐based (S2k) Guideline on the Management of Herpes Zoster–guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of … RN Werner, AF Nikkels, B Marinović, M Schäfer, M Czarnecka‐Operacz, ... Journal of the European Academy of Dermatology and Venereology 31 (1), 9-19, 2017 | 107 | 2017 |
Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke S Pikija, LK Sztriha, M Killer-Oberpfalzer, F Weymayr, C Hecker, ... Journal of neuroinflammation 15, 1-7, 2018 | 96 | 2018 |
Pathogenesis and pathophysiology of bacterial CNS infections J Sellner, MG Täuber, SL Leib Handbook of clinical neurology 96, 1-16, 2010 | 92 | 2010 |
Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment O Findling, J Sellner, N Meier, JHJ Allum, D Vibert, C Lienert, HP Mattle Experimental brain research 213, 363-370, 2011 | 91 | 2011 |
Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management J Sellner, E Trinka Journal of neurology 259, 2019-2030, 2012 | 87 | 2012 |
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): A randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy … A Uccelli, A Laroni, L Brundin, M Clanet, O Fernandez, SM Nabavi, ... Trials 20, 1-13, 2019 | 86 | 2019 |
Tumefactive MS lesions under fingolimod: a case report and literature review G Pilz, A Harrer, P Wipfler, K Oppermann, J Sellner, F Fazekas, E Trinka, ... Neurology 81 (19), 1654-1658, 2013 | 86 | 2013 |